COVID-19, steroids and diabetes webinar

• Understand how common steroid use is in the general population and their use in specific groups of people
• Be aware of the implications of steroid use on glucose control
• Have gained an understanding of steroid use in people seriously ill with the coronavirus
• Be aware of glucose-lowering therapies for steroid- induced hyperglycaemia
• Recognise the need for surveillance in people previously not known to have diabetes and those with pre-existing diabetes

This webinar is for UK healthcare professionals only.

To sign up for this webinar, click here.

This project has been funded by Sanofi who have had no input into any arrangements or content.